Literature DB >> 14730438

Anterior lumbar interbody fusion with carbon fiber cage loaded with bioceramics and platelet-rich plasma. An experimental study on pigs.

Haisheng Li1, Xuenong Zou, Qingyun Xue, Niels Egund, Martin Lind, Cody Bünger.   

Abstract

Platelet-rich plasma (PRP) is an autogenous source of growth factor and has been shown to enhance bone healing both in clinical and experimental studies. PRP in combination with porous hydroxyapatite has been shown to increase the bone ingrowth in a bone chamber rat model. The present study investigated whether the combination of beta tricalcium phosphate (beta-TCP) and PRP may enhance spinal fusion in a controlled animal study. Ten Danish Landrace pigs were used as a spinal fusion model. Immediately prior to the surgery, 55 ml blood was collected from each pig for processing PRP. Three-level anterior lumbar interbody fusion was performed with carbon fiber cages and staples on each pig. Autogenous bone graft, beta-TCP, and beta-TCP loaded with PRP were randomly assigned to each level. Pigs were killed at the end of the third month. Fusion was evaluated by radiographs, CT scanning, and histomorphometric analysis. All ten pigs survived the surgery. Platelet concentration increased 4.4-fold after processing. Radiograph examination showed 70% (7/10) fusion rate in the autograft level. All the levels with beta-TCP+PRP showed partial fusion, while beta-TCP alone levels had six partial fusions and four non-fusions ( P=0.08). CT evaluation of fusion rate demonstrated fusion in 50% (5/10) of the autograft levels. Only partial fusion was seen at beta-TCP levels and beta-TCP+PRP levels. Histomorphometric evaluation found no difference between beta-TCP and beta-TCP+PRP levels on new bone volume, remaining beta-TCP particles, and bone marrow and fibrous tissue volume, while the same parameters differ significantly when compared with autogenous bone graft levels. We concluded from our results in pigs that the PRP of the concentration we used did not improve the bone-forming capacity of beta-TCP biomaterial in anterior spine fusion. Both beta-TCP and beta-TCP+PRP had poorer radiological and histological outcomes than that of autograft after 3 months.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730438      PMCID: PMC3468048          DOI: 10.1007/s00586-003-0647-3

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  29 in total

1.  Posterolateral and anterior interbody spinal fusion models in the sheep.

Authors:  T Steffen; D Marchesi; M Aebi
Journal:  Clin Orthop Relat Res       Date:  2000-02       Impact factor: 4.176

2.  Platelet-rich plasma (PRP): what is PRP and what is not PRP?

Authors:  R E Marx
Journal:  Implant Dent       Date:  2001       Impact factor: 2.454

3.  The influence of intervertebral disc tissue on anterior spinal interbody fusion: an experimental study on pigs.

Authors:  Haisheng Li; Xuenong Zou; Malene Laursen; Niels Egund; Martin Lind; Cody Bünger
Journal:  Eur Spine J       Date:  2002-08-29       Impact factor: 3.134

4.  Use of autologous growth factors in lumbar spinal fusion.

Authors:  G L Lowery; S Kulkarni; A E Pennisi
Journal:  Bone       Date:  1999-08       Impact factor: 4.398

5.  Beta-tricalcium phosphate as a substitute for autograft in interbody fusion cages in the canine lumbar spine.

Authors:  Takashiro Ohyama; Yoshichika Kubo; Hiroo Iwata; Waro Taki
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

6.  The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier.

Authors:  Y M Lee; Y J Park; S J Lee; Y Ku; S B Han; P R Klokkevold; C P Chung
Journal:  J Periodontol       Date:  2000-03       Impact factor: 6.993

7.  Donor site pain from the ilium. A complication of lumbar spine fusion.

Authors:  B N Summers; S M Eisenstein
Journal:  J Bone Joint Surg Br       Date:  1989-08

8.  Effect of alendronate on bone ingrowth into porous tantalum and carbon fiber interbody devices: an experimental study on spinal fusion in pigs.

Authors:  Xuenong Zou; Qingyun Xue; Haisheng Li; Mathias Bünger; Martin Lind; Cody Bünge
Journal:  Acta Orthop Scand       Date:  2003-10

9.  Use of an advanced formulation of beta-tricalcium phosphate as a bone extender in interbody lumbar fusion.

Authors:  Raymond J Linovitz; Timothy A Peppers
Journal:  Orthopedics       Date:  2002-05       Impact factor: 1.390

10.  Use of a novel beta-tricalcium phosphate-based bone void filler as a graft extender in spinal fusion surgeries.

Authors:  Robert Gunzburg; Marek Szpalski
Journal:  Orthopedics       Date:  2002-05       Impact factor: 1.390

View more
  12 in total

Review 1.  Platelet concentrates in spine fusion: meta-analysis of union rates and complications in controlled trials.

Authors:  Julia Vavken; Patrick Vavken; Alexander Mameghani; Carlo Camathias; Stefan Schaeren
Journal:  Eur Spine J       Date:  2015-08-23       Impact factor: 3.134

Review 2.  Platelet-rich plasma and platelet gel: a review.

Authors:  Peter A M Everts; Johannes T A Knape; Gernot Weibrich; Jacques P A M Schönberger; Johannes Hoffmann; Eddy P Overdevest; Henk A M Box; André van Zundert
Journal:  J Extra Corpor Technol       Date:  2006-06

3.  Evaluation of autologous platelet concentrate for intertransverse lumbar fusion.

Authors:  Gonzalo Acebal-Cortina; Miguel A Suárez-Suárez; Constantino García-Menéndez; Luis Moro-Barrero; Roberto Iglesias-Colao; Ana Torres-Pérez
Journal:  Eur Spine J       Date:  2011-07-23       Impact factor: 3.134

4.  Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study.

Authors:  Yoshito Katayama; Yukihiro Matsuyama; Hisatake Yoshihara; Yoshihito Sakai; Hiroshi Nakamura; Shiro Imagama; Zenya Ito; Norimitsu Wakao; Mitsuhiro Kamiya; Yasutsugu Yukawa; Tokumi Kanemura; Koji Sato; Hisashi Iwata; Naoki Ishiguro
Journal:  Int Orthop       Date:  2008-06-26       Impact factor: 3.075

5.  Built-in microscale electrostatic fields induced by anatase-rutile-phase transition in selective areas promote osteogenesis.

Authors:  Chengyun Ning; Peng Yu; Ye Zhu; Mengyu Yao; Xiaojing Zhu; Xiaolan Wang; Zefeng Lin; Weiping Li; Shuangying Wang; Guoxin Tan; Yu Zhang; Yingjun Wang; Chuanbin Mao
Journal:  NPG Asia Mater       Date:  2016-03-04       Impact factor: 10.481

6.  Freeze-Dried Platelet-Rich Plasma Accelerates Bone Union with Adequate Rigidity in Posterolateral Lumbar Fusion Surgery Model in Rats.

Authors:  Yasuhiro Shiga; Sumihisa Orita; Go Kubota; Hiroto Kamoda; Masaomi Yamashita; Yusuke Matsuura; Kazuyo Yamauchi; Yawara Eguchi; Miyako Suzuki; Kazuhide Inage; Takeshi Sainoh; Jun Sato; Kazuki Fujimoto; Koki Abe; Hirohito Kanamoto; Masahiro Inoue; Hideyuki Kinoshita; Yasuchika Aoki; Tomoaki Toyone; Takeo Furuya; Masao Koda; Kazuhisa Takahashi; Seiji Ohtori
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

7.  Food for thought: Autophagy researcher wins 2016 Nobel Prize in Physiology or Medicine.

Authors:  Emma Louise Walton
Journal:  Biomed J       Date:  2017-03-31       Impact factor: 4.910

8.  Characterization of a novel caudal vertebral interbody fusion in a rat tail model: An implication for future material and mechanical testing.

Authors:  Yu-Cheng Yeh; Cheng-Chun Yang; Ching-Lung Tai; Tsung-Ting Tsai; Po-Liang Lai; Tsai-Sheng Fu; Chi-Chien Niu; Lih-Huei Chen; Wen-Jer Chen
Journal:  Biomed J       Date:  2017-03-15       Impact factor: 4.910

9.  LIPUS promotes spinal fusion coupling proliferation of type H microvessels in bone.

Authors:  Ximing Xu; Fei Wang; Yahong Yang; Xiaoyi Zhou; Yajun Cheng; Xianzhao Wei; Ming Li
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

10.  Autologous platelet-rich plasma induces bone formation of tissue-engineered bone with bone marrow mesenchymal stem cells on beta-tricalcium phosphate ceramics.

Authors:  Tengbo Yu; Huazheng Pan; Yanling Hu; Hao Tao; Kai Wang; Chengdong Zhang
Journal:  J Orthop Surg Res       Date:  2017-11-21       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.